Agios Pharmaceuticals (AGIO) Current Leases: 2019-2025
Historic Current Leases for Agios Pharmaceuticals (AGIO) over the last 7 years, with Sep 2025 value amounting to $18.0 million.
- Agios Pharmaceuticals' Current Leases rose 10.22% to $18.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.0 million, marking a year-over-year increase of 10.22%. This contributed to the annual value of $16.8 million for FY2024, which is 11.81% up from last year.
- Latest data reveals that Agios Pharmaceuticals reported Current Leases of $18.0 million as of Q3 2025, which was up 2.26% from $17.6 million recorded in Q2 2025.
- Agios Pharmaceuticals' 5-year Current Leases high stood at $18.0 million for Q3 2025, and its period low was $8.0 million during Q1 2021.
- For the 3-year period, Agios Pharmaceuticals' Current Leases averaged around $15.9 million, with its median value being $15.9 million (2024).
- Data for Agios Pharmaceuticals' Current Leases shows a peak YoY skyrocketed of 52.66% (in 2021) over the last 5 years.
- Quarterly analysis of 5 years shows Agios Pharmaceuticals' Current Leases stood at $10.8 million in 2021, then climbed by 26.18% to $13.7 million in 2022, then increased by 9.84% to $15.0 million in 2023, then grew by 11.81% to $16.8 million in 2024, then increased by 10.22% to $18.0 million in 2025.
- Its Current Leases stands at $18.0 million for Q3 2025, versus $17.6 million for Q2 2025 and $17.2 million for Q1 2025.